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Abstract
Background: The two-step transposition pathway of insertion sequences of the IS3 family, and several other
families, involves first the formation of a branched figure-of-eight (F-8) structure by an asymmetric single strand
cleavage at one optional donor end and joining to the flanking host DNA near the target end. Its conversion to a
double stranded minicircle precedes the second insertional step, where both ends function as donors. In IS2, the
left end which lacks donor function in Step I acquires it in Step II. The assembly of two intrinsically different
protein-DNA complexes in these F-8 generating elements has been intuitively proposed, but a barrier to testing
this hypothesis has been the difficulty of isolating a full length, soluble and active transposase that creates fully
formed synaptic complexes in vitro with protein bound to both binding and catalytic domains of the ends. We
address here a solution to expressing, purifying and structurally analyzing such a protein.
Results: A soluble and active IS2 transposase derivative with GFP fused to its C-terminus functions as efficiently as
the native protein in in vivo transposition assays. In vitro electrophoretic mobility shift assay data show that the
partially purified protein prepared under native conditions binds very efficiently to cognate DNA, utilizing both N-
and C-terminal residues. As a precursor to biophysical analyses of these complexes, a fluorescence-based random
mutagenesis protocol was developed that enabled a structure-function analysis of the protein with good
resolution at the secondary structure level. The results extend previous structure-function work on IS3 family
transposases, identifying the binding domain as a three helix H + HTH bundle and explaining the function of an
atypical leucine zipper-like motif in IS2. In addition gain- and loss-of-function mutations in the catalytic active site
define its role in regional and global binding and identify functional signatures that are common to the three
dimensional catalytic core motif of the retroviral integrase superfamily.
Conclusions: Intractably insoluble transposases, such as the IS2 transposase, prepared by solubilization protocols
are often refractory to whole protein structure-function studies. The results described here have validated the use
of GFP-tagging and fluorescence-based random mutagenesis in overcoming this limitation at the secondary
structure level.
Background
IS2, a 1.3 kb transposable element, is a member of the
IS3 family, the largest and most widespread family of
insertion sequences (IS) ([1,2]; see also ISfinder: http://
www-is.biotoul.fr/is.html). These insertion sequences are
characterized by terminal imperfect inverted repeats, the
r i g h t( I R R )a n dl e f t( I R L )e n d s ,t h a tf l a n ka ni n t e r n a l
protein coding sequence (Figure 1a). The latter is com-
prised of two -1 frameshifted overlapping open reading
frames, OrfA and OrfB (Figure 1a, i) and is regulated in
IS2 by a weak extended-10 promoter (E-10) promoter
(Figure 1b, ii). Within the overlap, a ribosomal slippage
window [3,4], characterized in IS2 by an A6G motif (Fig-
ure 1a, i), enables translational frameshifting to create
the functional transposase (TPase) at a low frequency
(OrfAB) but an A7G mutation (Figure 1a, ii) has per-
mitted the production of an engineered frame-fused
OrfAB as the principal translation product [5,6]. The
ends of these elements are bipartite structures (Figure
1b, upper) with internal protein binding domain and
outer catalytic domains (CD) [7,8] terminating in most
cases with a CA-3’ dinucleotide that is the essential
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any medium, provided the original work is properly cited.Figure 1 Organization of the IS2 insertion sequence and its transposition pathway. (A) Wild type IS2 with left and right inverted repeats
(IRL, blue; IRR, red) and the two overlapping open reading frames, orfA and orfB, expanded to show the detail of the A6G slippery codon
window which regulates low levels of OrfAB formation (i). High levels of the transposase (TPase) are produced by altering the window to A7G
(ii). (B)Upper. Aligned sequences of IRR and IRL ((i) and (ii)) with the binding domains (yellow) and color coded catalytic domains. Conserved
residues are in uppercase and diverged residues are in lower case. The catalytic domain (CD) of IRL contains an additional G/C base pair that is
essential for its role in target function [7]. The E-10 promoter, PIRL, [19] (ii) drives the events of Step I of the transposition pathway [6] resulting in
the formation of the minicircle shown in panel C. Lower: Abutted ends at the minicircle junction (MCJ), form a more powerful promoter (Pjunc)
which indispensably controls the events in Step II of the transposition pathway. The only functional form of Pjunc contains a single base pair
spacer (x) which creates the mandatory 17 bp spacer. (C) The two-step transposition pathway of IS2. Step I (I) occurs in the TPase-DNA complex,
the synaptic complex I (SC I). Asymmetric single strand cleavage of the active IRR donor is followed by strand transfer to the donor-inactive IRL
target end, creating the figure-of-eight structure. Host replication mechanisms (HR) convert it into a covalently closed double stranded circular
intermediate [10], the minicircle. In step II (II) a second synaptic complex (SC II) is assembled. Cleavages at the abutted CDs result in two
exposed 3’OH groups which carry out transesterification attacks on the target DNA. CD: catalytic domain; E-10: extended-10 promoter; IRR/IRL:
right and left inverted repeats; IS: insertion sequence; MCJ: minicircle junction; orf: open reading frame; SC: synaptic complex.
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tions, see [9]. In IS2, IRL terminates with a TA-3’ dinu-
cleotide which creates a functional Pribnow box for a
minicircle junction promoter (see below).
Transposition mechanisms, initially discovered in the
IS3 family (see [2]) have been described as a two-step
copy and paste pathway [10] which is now quite wide-
spread and is found in several other families of insertion
sequences, such as IS30,I S 21 and IS256 [11-14]. In IS3
family members, IS911 [8,15] and IS2 (Lewis et al,P r o -
tein-DNA interactions define the mechanistic aspects of
circle formation and insertion reactions in IS2 transposi-
tion, submitted), Step I occurs within a synaptic com-
plex (SC) or transpososome (Figure 1c, SC I) that is
formed when the TPase binds to the two ends. In gen-
eral, however, in these circle-forming elements the first
step involves a circularization process (Figure 1c) in
which either end (optionally) is the substrate for an
asymmetric cleavage reaction that leads to a donor-to-
target intrastrand joining reaction near the other end to
form a branched figure-of-eight (F-8) structure [6,16-18]
Host replication mechanisms [10] convert the F-8 into a
covalently closed double stranded minicircle (Figure 1c,
HR) with the abutted ends generally separated by one or
more base pairs derived from the host DNA flanking the
target end. These abutted ends constitute the minicircle
junction (MCJ) at which a powerful promoter (Figure
1b, lower;P junc [19-21]) is assembled and generates the
higher levels of TPase needed for the formation of the
second synaptic complex (Figure 1c, SC II).
In SC II, the MCJ, a reactive junction, is the substrate
for strand transfer reactions; it is cleaved at the abutted
termini of IRR and IRL, creating 3’OH groups which
permit both ends to function symmetrically as donors
(Figure 1c, Step II). Thus it has been proposed that
intrinsically different transpososomes must be assembled
at each of the two steps [7,8]. This is particularly true
for IS2. Although both right and left ends in other IS3
family elements, such as IS911 [16], IS3 [22] and IS150
[23], possess donor function in Step I reactions, in IS2
the right end is the exclusive donor and the left end the
only functional target; this type of asymmetry has also
been described for copies of IS256 in Tn4001 [13]. In
IS2, the left end has evolved through altered residues at
positions 2 (creating a TA-3’ terminal dinucleotide), 5
and 7 and an additional base pair at position 9 in its
catalytic domain (Figure 1b, upper)t ob e c o m eau n i q u e
target which ensures accuracy of the joining reaction
through the insertion of a single base pair between the
abutted ends [7]. This accuracy is essential for the for-
mation of an MCJ with a mandatory 17 bp Pjunc spacer
between the -10 Pribnow box and an outwardly reading
-35 motif in the right end [19]. Despite these changes in
the catalytic domain of IRL which suppress donor
function in Step I, IRL does possess the donor function
[19] needed for strand transfer to the target site in the
Step II SC.
IS3 family TPases have been identified as members of
the TPase/retroviral integrase superfamily (referred to as
RISF) of polynucleotidyl transferases [9,24-27] and func-
tional comparisons of their protein-DNA interactions
with those of other RISF TPases should be useful. To
date, a complete and comparative biophysical analysis of
the protein-DNA interactions in fully formed Step I and
Step II SCs with protein complexed to the protein bind-
ing and catalytic domains of the inverted repeats (IRs)
has not been reported for any IS3 family member or
other circle-forming elements, primarily due to the diffi-
culty in isolating full length proteins capable of binding
efficiently and generating fully formed complexes with
the IRs [8,28]. Partial footprints of the ends have how-
ever been carried out with cell-free extracts in IS2 [5]
and similar analyses carried out with the N-terminal
half of the truncated protein have been reported for
IS911 [8,15,17] and IS30 [29]. In order to carry out a
detailed biophysical study with fully formed complexes
in IS2 it was first necessary to resolve the problem of
the intractable insolubility of the TPase.
We report here a protocol utilizing a green fluorescent
protein (GFPuv) tag that generates an IS2 TPase deriva-
tive that functions normally in vivo.W es h o wf o rt h e
first time that preparation under native conditions
results in the recovery of a full length, soluble derivative
that, when partially purified, binds very efficiently to
cognate DNA sequences in vitro. This binding utilizes
residues at both the N- and C-termini of the protein
and is shown elsewhere to generate fully formed SCs
with double stranded cognate IRR, IRL and MCJ
sequences, with TPase bound to both the protein bind-
ing and catalytic domains of the ends (Lewis et al,P r o -
tein-DNA interactions define the mechanistic aspects of
circle formation and insertion reactions in IS2 transposi-
tion, submitted).
Although aspects of structure-function relationships of
the IS2 and IS911 TPases have been reported [30-34],
we show here, using the GFP-tagged TPase derivative,
that mutations which confer gain- or loss-of-function
that are readily recovered in all of the principal domains
of the protein (for examples, see Table 1) have been
used to confirm, extend and further refine these struc-
ture-function relationships in IS2 and other IS3 family
TPases. In addition, we have been able to describe the
role of a residue whose mutation appears to have conse-
quences primarily beyond its domain. Specifically, first
an N-terminal 3-helix (H + HTH) bundle constitutes a
binding domain whose architecture includes the HTH
motif in helices 2 and 3 and possesses at least one resi-
due in helix 3 which appears to play a more global role
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(CAS). Adjacent to this, is an atypical leucine zipper-like
motif, null mutations of which have allowed us to deci-
pher its mode of function in oligomerization and bind-
ing. Within the C-terminal half of the protein, a middle
domain is located adjacent to a 5a helix/5b strand sec-
ondary structure motif, the CAS, which is highly con-
served in the RISF. Gain- and loss-of-function
mutations in this latter domain help describe its role in
regional binding (that is, to the catalytic domain of the
ends (Lewis et al, Protein-DNA interactions define the
mechanistic aspects of circle formation and insertion
reactions in IS2 transposition, submitted) and global
binding of the protein; but equally importantly, they
give credence to the supposition that, at the tertiary
level, the organization and function of the CAS is simi-
lar to that of the three dimensional a/b/a catalytic core
motif of proteins of the RISF.
Results
Purification of the IS2 TPase by conventional methods
Conventional methods for purifying active full length
IS2 TPase under native conditions generated insoluble
protein as inclusion bodies. Although standard solubili-
zation protocols [35-37] and attempts at directed evolu-
tion [38] were unsuccessful, the protein was easily
purified to homogeneity using denaturing protocols and
refolded either on-column [39,40] or in solution [41-43]
in native buffers. In all cases, these TPase preparations
bound very poorly to oligonucleotide substrates contain-
ing the cognate IRR DNA sequence in gel-retardation
studies (for example see Figure 5a, lane 2).
Creation of an IS2orfAB::GFP fusion construct
Fusion of the GFPuv gene to the carboxy- but not the
N-terminus of IS2orfAB generated a soluble fusion pro-
duct under native conditions (see Methods). In brief,
Table 1 Distribution, from 23 recovered mutants, of 25 randomly induced mutations in the four domains of the IS2
OrfAB TPase
Domains
a
Wild type/
Mutants
b
1-14 13-60
H+HTH
61-69 70-103
LZ-L
104-206
MI
207
-235
236-292
(D240)
CAS
293-334
(D306)
CAS
335-398
(E342)
CAS
399-409
Wild type
03 R291H
04 A42T
06 Q79L
07 N94D
09 R50H
13 S57G
18 A42T L97H
22 A341P
24 L266P
28 S44N
29 L58I
31 V301M
34 R13H
36 R37Q/S44N
37 W49R
38 A341T
40 V35L
68 H267D
71 E391K
94 K89M
96 W237R
101 V179L
106 L83V
aDomains of the IS2OrfAB TPase, deduced from these studies are as follows: H + HTH: the Binding domain; LZ-L: Leucine zipper-like oligomerization motif; MI: the
middle interval; CAS: putative catalytic active site which extends from residue 236-398. The locations of the three catalytic carboxylates are shown. The sequence
associated with D240 includes the b strands 1-3, that with D306, b strands 4-5 and a helices 1-3 and that with E342 a helices 4-6. Intervals represented by the
numbers 1-14, 61-69, 207-235, and 399-409 are most likely disordered sequences (see Figure 9a).
bThe wild type fusion protein (OrfAB-GFP) was overexpressed
from the plasmid pLLIS2orfAB::GFP (pLL2522). Mutant proteins were overexpressed from the GMF strains carrying similar plasmids (pLL2524-XXX i.e., from 001-
110) carrying a mutagenized orfAB gene. Isolated GMF strains were numbered from 1-110.
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modified version of the commercially available pGLO
plasmid. The strategy was to clone an EcoRI-NheIc a s -
setted version of IS2orfAB (Figure 2d) into the cloning
sites created at the 5’ end the of the GFP gene to gener-
ate pLL2522 (IS2orfAB::GFP clones; Figure 2e). The
resulting slow growing colonies fluoresced much less
intensely than control colonies carrying only the pGLO
plasmid (Figure 3a).
Overexpression of the putative IS2OrfAB-GFP fusion
protein
We assumed that the presence of fluorescence in colo-
nies with the pLL2522 plasmid was an indication of a
soluble fusion protein, and the supposition that the
diminished fluorescence (see below) was not due to par-
tial solubility of the protein [44] was confirmed by the
presence of bright fluorescence of the supernatant after
a standard native lysis procedure. Partial purification
(see Methods) generated two prominent bands present
in these isolates following SDS-PAGE analysis (arrows;
Figure 4a, lanes 1-3 and 4b, lane 2) but absent from the
control pGLO (Figure 4b, lane 1) or the pGLO-ATG2
plasmids (Figure 4b, lane 3). These were determined to
b et h e7 4k D af u s i o np r o t e i n( t h e4 6 - k D aI S 2OrfAB
TPase and the 27 kDa GFP) and the 17.5 kDa OrfA pro-
tein, the product of ribosomal frameshifting [3,4]. The
74 kDa protein was also expressed from plasmid
pTW2orfAB::GFP,w h e r eorfAB::GFP was cloned into a
pTWIN2 vector (IMPACT; New England Biolabs, Ips-
wich, MA). In this case it was easily purified to near
homogeneity using the manufacturer’sp r o t o c o l ,f o l -
lowed by an ion exchange Q-sepharose polishing step
(HiTrap Q XL, GE Healthcare, Piscataway, NJ; Figure
4c).
Electrophoretic mobility shift assays with IS2OrfAB-GFP
Preparations of the OrfAB-GFP fusion protein purified
to near homogeneity also bound poorly to cognate DNA
sequences in gel retardation assays (Figure 5a, lane 3).
Figure 2 Structure of plasmids used to create the IS2OrfAB::GFP fusion construct. Modifications and alternations are indicated in red. (a)
pGLO-ATG2, a derivative of the commercially available pGLO plasmid (Biotechnology Explorer GFP Chromatography kit, Bio-Rad Inc., Hercules,
CA, USA) containing the GFPuv gene under the control of the PBAD promoter. An EcoRI-NheI cassetting site was created in the 5’ multiple
cloning site (MCS), to facilitate the cloning of the IS2orfAB fused frame gene. A unique EcoRI site was deleted from its position adjacent to the
GFP stop codon and transferred to a position downstream of the PBAD promoter and 9 bp from an existing NheI site which encodes the first
two amino acids of GFP. The mutagenizing primer for this last step also deleted the GFP start codon to create pGLO-ATG2. (b) pLL18, a pUC19
derivative with IS2 carrying the Km
r reporter gene [6]. IS2 in this construct contains the engineered orfAB gene described in Figure 1a (ii). (c)
pLL2509A was created by removing the left inverted repeats and repositioning the existing EcoRI site to a location downstream of the PIRL
promoter, effectively excluding this IS2 endogenous promoter from subsequent cloning of the cassetted orfAB gene. (d) pLL2521HK was created
by the successive steps of adding (i) the 3’-located cassetting NheI site which included the removal of the orfAB stop codon and (ii) the 6XHIS-
Tag, downstream of the EcoRI cassetting site. (e) pLL2522 was formed when the NheI-EcoRI cassetted orfAB (part d) was cloned into the
corresponding 5’ cloning site of pGLO-ATG2 (part a). bp: basepair; GFP: green fluorescent protein; IS: insertion sequences.
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tone-like protein, HU and integration host factor
[45-47] enhanced binding efficiency (data not shown).
On the other hand, the partially purified preparations of
OrfAB-GFP shown in Figure 4a, lanes 2-4, generated
results in which all of the DNA was driven into the
complex (Figure 5b, lane 2). A similar result was
obtained with the crude extract from the overexpression
of pTW2orfAB::GFP (Figure 5b, lane 3). The multimeric
nature of these complexes has been demonstrated in
concurrent footprinting studies in which complexes
similar to those shown in Figure 5b were created with
MCJ DNA substrates containing abutted IRR and IRL
ends. There, the protein binding domains and the
Figure 3 Comparative growth and fluorescence of colonies with the pGLO, pLL2522 and pLL 2524-XXX plasmids. (A) Contrasting
growth patterns of colonies of XL1 Blue cells of E. coli (Stratagene Inc.) transformed with (a) the pGLO plasmid and (b) the pLL2522 (IS2orfAB::
GFP) plasmid. Cells were plated on lysogeny broth (LB) plus carbenicillin and arabinose, incubated at 37°C for 48 hours and irradiated with UV
light. (B) XL1 Blue cells transformed with the ligation products generated by cloning PCR products recovered from the Genemorph II Random
mutagenesis of IS2orfAB DNA, into the EcoRI/NheI sites of pGLO-ATG2. Colonies were generated as described above and viewed after 72 hours at
37°C. Arrows identify the faster growing more brightly fluorescing colonies, the vast majority of which contained plasmids pLL2524-XXX
(IS2orfAB::GFP-GMF) with loss-of-function mutations in the orfAB gene. Isolated colonies at the periphery of the Petri dish (see white asterisk)
occasionally produced false positives without mutations or with silent mutations, for example, A42T. PCR: polymerase chain reaction.
Figure 4 12% SDS-PAGE analysis of proteins prepared under native conditions. (A) Analysis of fluorometrically determined peak fractions
from Ni-NTA gravity flow affinity chromatography purification of the 6xHis-tagged OrfAB-GFP. Lanes: 1. Prestained Protein Molecular Weight
markers (New England Biolabs). 2-4. Partial purification of the 74 kDa His-tagged OrfAB-GFP fusion protein (upper arrow) from cells with the
pLL2522 plasmid. The lower arrow identifies the 17.5 kDa OrfA protein generated by programmed -1 translational frameshifting. These lanes
represent peak fractions (determined fluorometrically) which were run out prior to pooling. (B) Analysis of the pooled fractions in part (A)
following concentration and dialysis (see Methods). Lanes: 1. Hydrophobic interaction chromatography purification of the 27 kDa GFP from cells
with the pGLO plasmid. 2. Pooled fractions from the purification protocol. 3. Protein preparation from the pGLO-ATG2 control plasmid. 4.
Prestained protein molecular weight markers. (C). Purification of the 74 kDa OrfAB-GFP fusion protein to near homogeneity with the IMPACT
system (New England Biolabs) from overexpression of the fused orfAB::GFP genes cloned into the pTWIN2 vector. The eluted protein was
subjected to a polishing step on an ion exchange Hi Trap Q sepharose column (GE Healthcare Biosciences). GFP: green fluorescent protein; kDA:
kiloDaltons; orf: open reading frame.
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their entire lengths, suggesting that the complex con-
sisted of at least a dimer (Lewis et al,P r o t e i n - D N A
interactions define the mechanistic aspects of circle for-
mation and insertion reactions in IS2 transposition,
submitted).
Fluorescence levels can be used to isolate IS2 TPase loss-
of-function mutants leading to a structure-function
analysis of the protein
We asked whether loss-of-function mutants of the IS2
TPase could be isolated as faster growing more brightly
fluorescing colonies in order to test the idea that the
low level of fluorescence of slow growing colonies with
the pLL2522 plasmid might be due to the toxicity of the
fusion protein, as well as to explore the possibility that
we could obtain and analyze random mutations along
the entire length of the protein. Random mutagenesis of
IS2orfAB was accomplished with the PCR-based
Genemorph II Random Mutagenesis kit (Stratagene,
Santa Clara, CA) using very low, low and medium muta-
tion rates. PCR products were cloned into the EcoRI/
NheI sites of pGLO-ATG2 and the ligation products
transformed into XL1blue cells (Stratagene). After 72
hours at 37°C, faster growing, more brightly fluorescing
colonies were observed among a background of less
intensely fluorescing colonies (Figure 3b). Recovery and
analysis of the plasmids pLL2524-XXX (that is, 001-110)
from these brighter fluorescing isolates (referred to here
as GMF strains 1-110) showed that they carried muta-
tions at frequencies which corresponded to the proto-
col-based mutation rates.
From the 110 brightly fluorescing colonies which were
isolated, twenty one orfAB sequences containing single
mutations and two with interesting double mutations
were successfully analyzed for the nature of their amino
acid substitutions (Table 1) and for the corresponding
effect of the substitutions on transposition frequencies
Figure 5 Electrophoretic mobility shift assays using purified and partially purified preparations of the IS2OrfAB-GFP fusion protein. (A)
Purified OrfAB-GFP fusion protein preparations shown in Figure 4c and the purified native protein from refolding experiments were used in gel
retardation reactions. 0.46 μM of the fusion protein and 6.02 μg of the refolded protein were reacted for 30 minutes at room temperature (20°C)
with 2 nM of
32P-labeled annealed 87-mer oligonucleotides containing the 41 bp inverted right repeat sequence. The reactions were run at 4°C
at 120 mA for 2400 Vhr in a 5% native polyacrylamide gel. The arrow shows complexes formed with low efficiency. Lanes: 1. Protein-free control.
2. Refolded native OrfAB. 3. OrfAB-GFP. (B) Partially purified preparations of the OrfAB-GFP fusion protein shown in Figure 4a and crude extracts
from overexpression of the pTW2 OrfAB-GFP construct used in binding reactions. Approximately 80 nM of the protein from the partially purified
preparations shown in Figure 4a and from the crude extracts were reacted with 2 nM of the
32P-labeled annealed 87-mer oligonucleotides as
described in part A. The reactions were run for 1400 Vhrs at 4°C. Lanes: 1. Protein-free control. 2. Partially purified preparation of OrfAB-GFP. 3.
Crude extract from the overexpressed pTW2 OrfAB-GFP plasmid. Bp: base pairs; GFP: green fluorescent protein; orf: open reading frame; Vhr: volt
hour.
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In addition, the relative binding efficiencies of the TPase
to the cognate IRR DNA sequence from 22 of the 23
mutants were determined on electrophoretic mobility
shift assay (EMSA) gels (Figure 6 and Tables 1 and 2).
Sequence analysis of the wild type IS2 TPase and
secondary structure analysis of the IS3 family TPases
The wild type IS2orfAB DNA sequence and those of five
other members (IS861,I S 3,I S 911,I S 407,a n dI S 51)o f
the five principal sub-groups of the IS3 family [1,30]
were translated into the protein sequences using the
ExPASy SWISS PROT translation toolkit [49]. These
sequences were aligned using the ClustalW2 multiple
sequence alignment tool [50] producing many groups of
short aligned sequences (Figure 7) which were then ana-
lyzed for their secondary structure (Figure 8) using the
Protein Structure Prediction (PSIPRED) Server [51]. Fig-
ure 7 merges the sequence alignment data and the sec-
o n d a r ys t r u c t u r ed a t af o rI S 2 and describes a pattern
Table 2 In vitro electrophoretic mobility shift assays, binding efficiencies and in vivo LacZ papillation assay-
determined transposition frequencies from IS2 wild type and mutant (GMF
a, d) isolates
Column
number
12 3 4 5 6 7 8 9
Row
number
Description of wild
type and mutant GMF
plasmids/strains.
Binding
efficiency
a
Description
or mutation
Domain-
location of
mutations
b
Total
number
of
colonies
Number
of trials
(n)
Number of
colonies with
papillae
Total
number
of
papillae
Transposition
frequency
c
1 pUH2523ΔorfAB
c - Null - 83 5 14 15 0.18 ± 0.16
2 pUH2509
d - WT OrfAB - 96 2 66 137 1.25 ± 0.23
3 pLL2522
a/pUH2523
d 5.0 WT fusion
protein
- 174 6 95 254 1.28 ± 0.09
4 pLL2524
a/pUH2524-004
d 5.0 A42T H + HTH 43 3 24 64 1.31 ± 0.20
5 -009 3.0 R50H H + HTH 18 1 2 2 0.00
6 -013 3.0 S57G H + HTH 66 4 26 33 0.32 ± 0.17
7 -028 0.0 S44N H + HTH 59 2 18 24 0.23 ± 0.08
8 -029 0.0 L58I H + HTH 68 2 14 17 0.07 ± 0.07
9 -034 0.0 R13H H + HTH 97 2 12 12 0.00
10 -036 2.0 R37Q/S44N H + HTH 162 4 51 73 0.27 ± 0.11
11 -037 5.0 W49R H + HTH 62 2 4 4 0.00
12 -040 4.0 V35L H + HTH 52 3 38 75 1.26 ± 0.18
13 -006 2.5 Q79L LZ-L 137 3 10 10 0.00
14 -007 3.0 N94D LZ-L 52 2 14 16 0.13 ± 0.09
15 -018 3.5 A42T/L97H
e LZ-L 44 2 13 17 0.21 ± 0.15
16 -094 ND K89M LZ-L 43 3 2 2 0.00
17 -106 0.0 L83V LZ-L 133 4 4 4 0.00
18 -003 2.5 R291H CAS 59 1 11 10 0.00
19 -022 2.0 A341P CAS 88 5 16 18 0.09 ± 0.11
20 -024 0.5 L266P CAS 34 2 4 4 0.00
21 -031 0.5 V301M CAS 60 2 2 2 0.00
22 -038 5.0 A341T CAS 37 2 30 80 1.98 ± 0.21
23 -068 2.5 H267D CAS 106 3 17 19 0.00
24 -071 2.5 E391K CAS 139 4 19 28 0.20 ± 0.26
25 -096 5.0 W237R CAS 80 4 10 16 0.02 ± 0.05
26 -101 3.0 V179L MI 113 4 7 10 0.00
aBinding efficiencies were determined from electrophoretic mobility shift assays as described in the Methods section and illustrated in Figure 6. The wild type
OrfAB-GFP fusion protein was expressed from pLL2522 and mutant OrfAB-GFP-GMF proteins from pLL2524-XXX plasmids (1-110).
bDomains and locations of
mutations are as described in Table 1.
cTransposition frequencies were calculated as the number of papillae per colony (column 8 divided by column 5) minus
the background frequency of transposition calculated from the null mutation (row 1). Frequencies shown for the mutants reflect only their contributions to the
observed results (column 8/column 5). When 0.0 is listed, the observed result is less than the background frequency probably due to experimental erroro r
variation in the count which may have been a function of sample size. The null mutation was derived from self ligation following an MfeI digestion which
removed most of the IS2orfAB::GFP fusion from the pUH2523 plasmid. The background frequency of transposition from the null mutant is likely due to the
presence of IS2 copies on the chromosome of JM105 into which plasmids used in the LacZ assay were transformed (see Methods).
dPlasmids used to determine
transposition frequencies by means of the LacZ papillation assay were pUH2509 for the WT OrfAB protein, pUH2523 for the WT OrfAB-GFP protein and pUH2524-
XXX (1-110) for the mutant OrfAB-GFP-GMF proteins.
eThe phenotype of GMF 18 is attributed to the L97H substitution since both the binding efficiency and the
transposition frequency of the A42T substitution (row 4) do not differ statistically from those of the wild type (row 3). CAS: putative catalytic active site; H + HTH:
the binding domain; LZ-L: leucine zipper-like oligomerization motif; MI: the middle interval; WT: wild type.
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Page 8 of 28that is essentially conserved in all of the five principal
subgroups of the IS3 family (data not shown).
Although DNA binding domains in TPases have long
been identified at their N-termini [52] and an HTH
motif for the IS911 TPase in the IS3 family has been
confirmed experimentally by Rousseau et al. [34], the
precise nature at the secondary structure level of all ele-
ments which contribute to the three-dimensional archi-
tecture of the binding domain in this family, and
specifically in IS2, has not been demonstrated (see
[5,33]). We asked whether the three N-terminal a
helices might comprise such a binding domain in IS2
and used the PSIPRED server [53] (Figure 9a) and the
PHD secondary structure analysis algorithm (Pole Bioin-
formatique Lyonnais (PBIL; [54,55]) to arrive at a con-
sensus that the location of three a helices in a putative
b i n d i n gd o m a i ni nt h eI S 2 TPase was somewhere
between residues 13 and 55 (Figure 9b). In addition, a
PBIL-HTH Determination Algorithm based on the pro-
tocol of Dodd and Egan [56] detected an HTH motif at
residues 30-51 (Figure 9c) corresponding approximately
to helices 2 and 3 in Figures 8, 9a and 9b. Similar
Figure 6 Electrophoretic mobility shift assays. Binding efficiencies of the IS2OrfAB Transposase derivatives from 22 randomly induced
mutants. Reactions were carried out for 30 minutes at 20°C, with 10 nM of
32P-labeled annealed 50-mer oligonucleotides (except where stated
in part (f) below) containing the inverted right repeat sequence and 0.11 μM of the partially purified mutant or wild type IS2OrfAB-GFP protein
derivatives (see Methods). Domain locations of the substitutions are color-coded and identified by a single letter code, that is, the binding
domain (B) yellow, the leucine zipper-like (L) blue, the catalytic active site (C) green, and the middle interval (M) orange. Reactions were
separated on 5% native polyacrylamide gels at 4°C at 120 mA as follows: (a) 450 Vhrs. (b) 420 Vhrs (c) 300 Vhrs (d) 450 Vhrs (e) 450 Vhrs (f) 12%
native PAGE for 300 Vhrs using 87-mer annealed oligonucleotides. Binding efficiencies are identified as follows: 5 = Identical to that of the wild
type, that is, absence of any dissociation of the complex. 4.5 = a slight loss of compactness of the undissociated complex seen in the wild type
control. 4.0 = as in 4.5 but with a faster migrating tail of dissociated complexes. 3.5 = as in 4.0 but with a more prominent faster migrating tail
of dissociated complexes. 3.0 = significant loss of compactness of the complex with a small amount of uncomplexed DNA. 2.5 = as in 3.0 but
with significantly more uncomplexed DNA. 2.0 = as in 3.0 but mostly composed of uncomplexed DNA. 0.5 = mostly composed of uncomplexed
DNA with a small tail of dissociated complex. 0 = no complex formation, identical to that of the protein-free controls (lane 1 in each panel) or
the GFP control (part a lane 10). Double mutations are indicated within rectangular boxes. For GMF 18 the operative mutation, L97H, is shown in
red (gel c, lane 4). GFP: green fluorescent protein; orf: open reading frame; Vhr: volt hour
Lewis et al. Mobile DNA 2011, 2:14
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Page 9 of 28Figure 7 Alignment of OrfAB sequences from IS3-family sub-groups correlated with secondary structure data of IS2. Sequences in descending order, IS861 (IS150 subgroup), IS3,I S 911
(IS3 subgroup), IS2,I S 407 and IS51 were aligned using the ClustalW2 multiple sequence alignment tool [50]. Coordinates above the sequences are those of IS2. Amino acid groups are color
coded as follows: Red - acidic residues; blue - basic residues; green - non-polar hydrophobics; cyan - aromatics (Y and F); dark green - tryptophan; gray - proline; light purple - amides; blue-gray
- small polar; aquamarine - small non-polar; ochre - glycine; magenta - histidine and brown - cysteine. Secondary structure elements (green cylinders for a helices and red arrows for b strands)
for IS2 were determined by the Protein Structure Prediction Protocol (see Figure 8) and are shown above the sequences for the N-terminus of the protein as B a1-3 (putative binding domain),
the putative leucine zipper-like domain and the middle interval (elements M a1-7). In the C-terminal half of the sequences, elements of a putative catalytic active site motif are identified as C b
1-5 and C a 1-6. IS: insertion sequence.
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8predictions have been made for the existence of an
HTH motif in IS2 (residues 31-50) [5,33] and in the IS3
family (including IS2, residues 30-55) [34], with the
assumption in the latter study that a third N-terminal
helix might form part of the binding domain. In this
study we show through randomly recovered mutations
that the binding domain of the IS2 TPase at a secondary
level consists of a three-helix H + HTH bundle and pro-
vide evidence for the precise locations of the three
helices.
AP C O I L Sa n a l y s i sf o rc o i l ed coils [57,58] predicted
the presence of a coiled coil motif (Figure 9a) in the
IS2 TPase between residues 73 and 100. Lei and Hu
[33], using deletion derivatives of IS2 OrfA, showed
that a sequence between residues 58 and 105 was
responsible for dimerization and they as well as Haren
et al. [30], predicted that the sequence between resi-
dues 73 and 100 of IS2 OrfA possessed an atypical
heptad repeat showing some similarities to the canoni-
cal leucine zipper (LZ) of DNA binding proteins. In
this study, however, a probe for the potential for a LZ
within the first 120 residues of IS2 OrfAB was scored
at a probability of zero using the 2ZIP server [59] even
though the existence of a coiled coil domain between
residues 73 and 100 was confirmed with a probability
of 0.8 to 1.0. Here, we show through the use of loss-
of-function point mutations how this sequence func-
tions as an LZ-like motif and describe its role in the
oligomerization, DNA binding and transposition prop-
erties of the IS2 TPase.
Figure 8 Secondary structure elements of the IS2 OrfAB TPase. Elements were generated by the Protein Structure Prediction server [51]. The
transposase (TPase) sequence has been color coded to identify the four putative domains; binding (yellow), oligomerization (leucine zipper-like;
blue), a middle interval (orange) and the catalytic active site (CAS; green). The numbering of a helix #7 in the middle interval is designed here
to reflect the alignment of the six principal a helices found in the IS3 family (Figure 10a). Numbering of a helices 2 and 3 in the CAS reflects
the organization of the aligned elements in TPase and integrase sequences of the TPase/retroviral integrase superfamily (Figure 9c). Vertical
arrows and substituted amino acids identify the locations of the 23 substitutions within the secondary structures of the IS2 TPase. CAS: catalytic
active site; TPase: transposase.
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400 in Figure 7 matches that previously published for
the IS3 family TPases and the retroviral integrases [60],
as well as for the IS3,I S 4 and IS6-family TPases and
integrases from several retroelements residues 236-354
[61]. The latter sequence, the CAS, is characterized by
the presence of an invariant triad of catalytic carboxy-
lases, the D, D(35)E motif [9,27,62,63]. We asked what
degree of correlation might exist between the aligned
residues 101 to 400 in Figure 7 and a structure-based
alignment of the sequences of the a helices and b
strands generated by PSIPRED analysis in Figure 8; that
is, how similar would thesee l e m e n t sb ei ns e q u e n c e
and length in the IS3 family TPases and in the HIV-1
and Rous sarcoma virus (RSV) integrases.
Of the six alpha helices in a middle interval (residues
105 to 210 of IS2), from all six TPases in the IS3
family sub-groups (Figure 10a), only a helices 2, 5 and
6 were well aligned. Only a helices 4, 5 and 6 in the
IS3 family, located just upstream of the CAS (Figure
8), aligned with the NH2-terminal a helices of the
integrases.
Structure-based sequence alignments of residues cor-
responding to residues 236 to 398 in IS2 for IS3 family
Figure 9 Secondary structure predictions for the first 120 amino acids of the IS2 OrfAB TPase. (A) Comparison of secondary structure
predictions based on the Protein Structure Prediction server protocol [51] and the PROF Secondary Structure Protocol [53]. The PCOILS analysis
for coiled coils [57,58] is also shown. Disordered regions (D) determined by the VSL2 predictor package from the DisProt database [111,112]
correspond well with these secondary structure predictions. (B) Secondary structure analysis of the first 60 amino acids of the IS2 TPase
generated by the Pole Bioinformatique Lyonnais [54] PHD Secondary Structure Analysis algorithm [55]. H/h = alpha helix; C/c = random coil and
e = extended strand. (C) Identification of a putative HTH motif in the first 60 amino acids of the IS2 TPase generated by the Pole
Bioinformatique Lyonnais HTH Determination Algorithm of Dodd and Egan [56]. TPase: transposase.
Lewis et al. Mobile DNA 2011, 2:14
http://www.mobilednajournal.com/content/2/1/14
Page 12 of 28 
Figure 10 Structure-based alignments of middle interval and catalytic active site elements of IS3-family transposases and HIV-1 and
Rous sarcoma virus integrases. (A) a helices identified in the middle interval of the IS2 transposase (TPase) and the corresponding sequences
of five other members of the principal sub-groups in the IS3 family. Where applicable, the sequences of corresponding elements in the Rous
sarcoma virus (RSV) and the HIV-1 were also aligned (red lettering). All coordinates are those of IS2. Functionally conserved non-polar
hydrophobic residues are highlighted in yellow and identified as h1 and h2 (Methods - alignment tools). Functionally conserved basic residues
(b) are highlighted in blue. NA = no alignments identified in the integrases of RSV and HIV-1. (B) a helices and b strands in the catalytic active
sites (CASs) of the TPases of IS2, five other IS3 family members, and the integrases of RSV and HIV-1 (red lettering). Functionally conserved
hydrophobic and basic residues are identified as described in part A. In addition, functionally conserved acidic residues or their amides (a) are
highlighted in purple, non-polar aromatics (aro) in green, polar serines and/or threonines (p) in orange and prolines (pro) in mauve. DDE
residues are indicated by large black dots. Sequences in parentheses are not components of the a helices or b strands. a helix 2 (2+3) in the
TPases aligns with helices 2 and 3 in the integrases. Residues conserved in a helix 2 of the integrases and in its remnants in IS407, are enclosed
in a black rectangle. Large double asterisks indicate short a helices with no homology to other sequences (see part C graphic). Substitutions are
indicated by red ovals; twin ovals indicate A341P and A341T. (C) Graphic alignment of a helices and b strands of the CASs of the TPases of IS2
and five other members of the IS3 family and of the integrases of RSV and HIV-1. Black dots within the elements represent the positions of the
DDE triad. DDE: the catalytic triad of two aspartates and a glutamate; CAS: catalytic active site; IS: insertion sequence; RSV: Rous sarcoma virus;
TPase: transposase.
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ies of five well-aligned a helices and five equally well-
aligned b strands (Figure 10b), showing almost perfect
conservation in their lengths, with high levels of identity
(the presence of the same amino acid in at least 85% of
the eight sequences) and high proportions of function-
ally conserved residues per element (approximately 50%
in the b strands and 25% in the a helices). The signifi-
cance of this in this study is that all but one of the eight
random mutations recovered in this domain occurred at
these conserved residues.
These a helices and b strands occur in a conserved
order (Figure 10c) characteristic of the integrases and of
the TPases with the DDE motif of two aspartates and a
glutamate, for example, Mu [64], Tn5 and the IS1 family
[65,66]. In IS3 family TPases, a h e l i c e s2a n d3i nt h e
integrases are present as a single helix (a helix 2) and it
is interesting that remnants of a helix 2 of the inte-
grases are seen in IS2 and IS407 but specifically in
IS407, as two well-conserved residues in the first three
amino acids of the single a helix (Figure 10b). In IS911
of the IS3 family, this group of tightly conserved ele-
ments has been proposed to be the putative CAS
[2,24,34].
The three-dimensional structure of this unit, the cata-
lytic core, has been demonstrated in several members of
the TPase/RISF, including the TPases of the DDE
family, such as Mu [64] and Tn5 [67], the integrases,
such as HIV-1 [68-71] and the avian (ASV) and Rous
(RSV) Sarcoma viruses [72,73] and other nucleases, for
example, RNase H1 [74,75] and RuvC [76]. For compre-
hensive reviews see [25,26,77]. This catalytic core is
characterized by a five-stranded partially buried b sheet
of mixed parallel and antiparallel elements with a polar
face, with six a helices distributed on either side of it.
The two aspartate residues of the DDE catalytic triad
are located on adjacent strands of the b sheet (numbers
1 and 4) with the glutamate residue assigned to the clo-
sely located a helix 4 [78]. We show here that randomly
induced mutations in this putative catalytic core that
affected residues other than the DDE alter the function
of this motif in both positive and negative ways, identi-
fying additional signatures characteristic of the catalytic
core and supporting the intuitive contention that, in the
IS3 family, it is organized and functions like the three-
dimensional structure in the RISF; additional mutations
also provide insights into its role in both the regional
and the global binding strategies of the protein.
Effect of TPase mutations on TPase binding efficiencies
and on in vivo transposition frequencies of IS2
Eleven of the twenty-five mutations (from the twenty-
one single mutants and two double mutants) were
within the putative binding domain, five were located in
the coiled coil domain, eight in the putative CAS and
one in the middle interval (Table 1; see also Figure 8 for
an overview of the locations of these mutations within
the secondary structures of the TPase). The binding effi-
ciencies of the partially purified TPases of 22 of the
mutant proteins were studied by EMSA (Figure 6) using
a pair of annealed oligomers (50 bp in length) contain-
ing 41 bp of cognate DNA of the IRR [6]. The substrate
was labeled at the 5’ end of the upper strand with g
32P
(see Methods). A summary of the binding efficiencies
together with results of in vivo transposition frequencies
of all 23 mutants (determined from lacZ transposition
assays) is shown in Table 2.
The putative binding domain
Nine mutants with substitutions in the putative binding
domain are described in Table 2 (rows 4-12). Binding
data are shown in the EMSA gel (Figure 6, yellow high-
lights). Proteins from three of the mutants, GMF isolates
28 (S44N), 29 (L58I) and 34 (R13H) (Figure 6a, lanes 7-
9) formed no complexes, indicative of structural defects.
The TPase from the double mutant, GMF 36 (R37Q/
S44N- Figure 6b, lane 2), however, showed a partially
restored, unstable, dissociated complex, absent in isolate
28 (S44N). Two GMF isolates, 9 (R50H; Figure 6a, lane
5) and 13 (S57G; Figure 6c, lane 2) also produced pro-
teins which formed mostly dissociated complexes, likely
indicative of deficiencies in binding reactions to the
DNA substrate (see discussion). All six of the mutants
with TPases completely defective or deficient in binding,
(GMF isolates 9, 13, 28, 29, 34 and 36) had significantly
reduced or no detectable levels of transposition (Table
2, rows 5-10). The remaining three mutants with substi-
tutions in the putative binding domain, GMF isolates 4
(A42T; Figure 6c, lane 3), 37 (W49R) and 40 (V35L)
(Figure 6b, lanes 3 and 5) showed marginal or no obser-
vable effects on binding efficiency. Two of these three
mutants, GMF isolates 4 (A42T) and 40 (V35L) (Table
2, rows 4 & 12) had in vivo transposition frequencies
(approximately 1.3) that were statistically comparable to
those of the wild type controls, two versions of which,
one fused to GFP (Table 2, row 3) and the other not
(Table 2, row 2), showed identical transposition frequen-
cies within experimental error.
The third mutant with little or no loss of binding effi-
ciency, GMF 37, (W49R) was the single exception to the
consistency in the relationship between binding effi-
ciency and transposition frequency described above
(Table 2, row 11). While this TPase derivative was quite
proficient in binding to the substrate, the substitution
completely abolished transposition. The apparent incon-
sistency in these properties of GMF 37 can be explained
b yt h ef a c tt h a tW 4 9i nI S 2,w h i c hi so n eo ft h em o s t
highly conserved residues in the IS3 family (Figure 7
Lewis et al. Mobile DNA 2011, 2:14
http://www.mobilednajournal.com/content/2/1/14
Page 14 of 28and [34]) and is also conserved in the homeodomain
proteins [79], may play a more global role in effecting
transposition. It may not simply be limited to a binding
domain function and is not likely to be involved in
DNA sequence recognition in helix 3 (see discussion).
The abolition of both DNA binding and in vivo trans-
p o s i t i o ni nR 1 3 Ha n dL 5 8 I( T a b l e2 ,r o w s8a n d9 )a n d
the significant reduction in transposition frequency and
binding in S57G (Table 2, row 6), suggest that the archi-
tecture of the binding domain consists of a three helix
bundle encompassing residues 13 to 58. Furthermore,
the ability of the R37Q/S44N double substitution in
helices 2 and 3 (Table 2, row 10) to partially restore
both the binding and transposition lacking in S44N, sug-
gests that they may be involved in the H-bonded stabili-
z a t i o no ft h et w oh e l i c e sw h e r et h eH T Hm o t i fm a yb e
located (see Figure 11 and the discussion section for a
complete elaboration of these ideas).
The coiled coil motif
Five of the randomly induced mutations (in GMF isolates
6, 7, 18, 94 and 106) fell into the coiled coil segment
(Table 2, rows 13-17 and Figure 10, blue highlights).
Although isolate GMF 18 carries the double substitutions
A42T+L97H, its phenotype, that is the loss of transposi-
tion and an unstable complex (Table 2, row 15; Figure 6a,
lane 6) should be allocated to L97H, since analysis of the
A42T mutation showed that the transposition frequency
of the GMF 4 mutant and the binding efficiency of its pro-
tein are identical to those of the wild type. Another
mutant, GMF 106 (L83V; see Figure 6d, lane 5), showed
complete loss of binding proficiency and two others, GMF
6 (Q79L; Figure 6a, lane 4) and 7 (N94D; Figure 6c, lane
5) showed marked dissociation of their complexes in the
EMSA gel. All five mutations effectively eliminated trans-
position (Table 2, rows 13-17).
The four heptads which make up the putative LZ
motif in the IS2 TPase and the substitutions within
them are shown in Figure 12a. This proposed LZ motif
contains zipper-functional leucines in only two of the
four d positions that are assigned to a canonical LZ
[80,81]; see also the aligned sequences of predicted LZ
sequences in the IS3 family [30]. Two of the five ran-
domly induced substitutions in the coiled coil segment,
L97H (GMF 18) and L83V (GMF 106) affected these
hydrophobic residues. The three other substitutions also
affected residues that are critical to the function of a
LZ-like motif; Q79L (g) and N94D (the a-located buried
Asn) likely affected residues that are required for inter-
subunit stabilization and K89M appears to have altered
a c position residue essential for the integrity of the
helical structure. Figure 12 and the discussion section
contain a detailed explanation of how all five of these
randomly isolated mutations resulted in amino acid
Figure 11 Analysis of locations and phenotypes of nine randomly induced substitutions in the binding domain of IS2OrfAB. Location
of the three a helix bundle which constitutes the binding domain (green cylinders) is based on the prediction of the PBIL-PHD Secondary
Structure Analysis Algorithm ([55]; see Figure 9b). The sequence in red indicates the prospective HTH motif identified by the PBIL- HTH
Determination Algorithm of Dodd and Egan [56]. The Pabo and Sauer [95] consensus sequence for prokaryotic HTH motifs is shown within the
large brackets and correlates well with this prospective motif (red lettering). Four of the nine mutations fell within this 12-residue consensus
sequence including the double mutation represented by the combination of the red bracket and the hooked arrow. The phenotype of this
double mutation is indicated by the vertical red arrow. Binding efficiencies are as described in Figure 6 and transposition frequencies were
calculated as described in Table 2.
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Page 15 of 28Figure 12 Analysis of the coiled coil domain in IS2OrfAB aligned with similar domains in the IS3 family. (A) The coiled coil sequence in
IS2 identified by the PCOILS analysis of coiled coils [57,58] annotated to show the four putative heptad repeats of a leucine zipper-like motif.
Italicized letters a to g represent the repeated positions within each heptad. The critical d positions which favor hydrophobic leucines are
highlighted in green (or in red for a non-canonical amino acid). The a-located buried asparagine (N94) is shown in red while green lettering
identifies the three canonical a-located hydrophobics. The five randomly induced mutations are indicated by arrows. The corresponding GMF
mutant strain is listed beneath each mutation. (B) Alignment of the coiled coil domains of seven members from the five principal subgroups of
the IS3 family showing their relationships to the putative heptads of a leucine-zipper motif. Annotation is as described in part A but for the IS2
sequence the a positions are highlighted in aqua. (C) Analysis of the potential of the coiled coil sequence in IS2 to function as a leucine zipper
and the effect of mutations recovered within the motif on that function. The data suggest that the sequence which fails the 2ZIP test for a
leucine zipper [59] may indeed have that function. Stabilization by the two d-located leucines is indicated by vertical bold green lines, by the a-
located hydrophobics by narrow green lines and by the buried asparagine by a vertical broken red line. Weak salt bridges between glutamines
in the g and e locations in heptads 1 and 2 are indicated by a large narrow-lined red × and the canonical ionic salt bridges between the g and
e-located E and K residues in heptads 3 and 4, are indicated by a large bold red X. Binding efficiencies (see Figure 6) and transposition
frequencies (see Table 2) are listed below the schematic. Additional annotation is as described in part A. GFP: green fluorescent protein; IS:
insertion sequence.
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function of the domain.
The catalytic active site
Eight of the twenty-five mutations occurred in the pro-
posed CAS of the protein (see GMF isolates 3, 22, 24,
31, 38, 68, 71 and 96 in Table 2, rows 18-25) and seven
of them altered conserved residues (Figure 10b). EMSA
gel reactions are shown in Figure 6 (green highlights).
Three protein derivatives from GMF 22, 24 and 31
(A341P, L266P and V301M (Figure 6e, lanes 2-4) pro-
duced no complexes. Three others showed mostly disso-
ciated complexes, GMF 3 (R291H; Figure 6a, lane 3),
GMF 68 and 71 (H267D and E391K; Figure 6d, lanes 2-
3). Two mutant derivatives with proficient binding reac-
tions were GMF 38 (A341T; Figure 6b, lane 4) and
GMF 96 (W237R; Figure 6f, lane 4); of these, the trans-
position frequency in the former was enhanced by about
50% and abolished in the latter (Table 2, rows 22 and
25). Transposition was eliminated in the six mutant
derivatives with deficient or completely defective binding
reactions (Table 2, rows 18-21 and 23-24). The locations
of these substitutions in three a helices and three b
strands of the CAS are shown in Figure 10b. Two of the
eight substitutions altered residues conserved only in
the IS3 family (R291H and V301M), one affected a non-
conserved residue (H267D) and the remaining five sub-
stitutions resulted from alterations of residues conserved
in the RISF.
The six TPase derivatives whose binding efficiencies
were partially or completely reduced give some insight
into the role of the putative catalytic core’s contribution
to both regional (catalytic domain) and global (catalytic
and binding domains) binding of the TPase. Three
mutations eliminated global binding, indicative of the
structurally destabilizing effects of the substitutions. The
A341P substitution located one residue from E342 of
the DDE catalytic triad altered a residue at a position
normally conserved for a hydrophobic amino acid in a
helix 4 of the RISF. The presence of the helix-breaking
proline had a devastating effect on binding and most of
the DNA remained uncomplexed (Figure 6e, lane 2).
Binding of the protein was completely eliminated in two
other derivatives (Figure 6e, lanes 3-4). First, the L266P
substitution occurred in b strand 3 where proline
replaced a hydrophobic residue that is essentially con-
served in the RISF; secondly, V301M changed another
very hydrophobic residue that is conserved the IS3
family as either a valine or leucine in b strand 4 and is
located adjacent to the second Asp of the DDE triad in
the RISF (D306 in IS2).
EMSA gels of TPase derivatives with three other sub-
stitutions showed reactions in which unstable complexes
were formed, suggestive of a reduction in the binding
affinity of the CAS for its DNA contacts. R291H altered
a positively charged residue in a helix 1, which is essen-
tially invariant in the IS3 family, for one which readily
assumes a neutral state (Figure 6a, lane 3). E391K sub-
stituted a basic residue for one which is essentially con-
served as glutamate or glutamine in a helix 6 of the
RISF. H267D substituted a negatively charged residue at
a non-conserved position in b strand 3 (Figure 6d, lanes
2-3). The combined results from these six substitutions
suggest that the catalytic core plays a role not only in
binding to the catalytic domain of the end (unstable
complexes) but that its integrity contributes to global
binding proficiency of the full length protein (see
Discussion).
Two mutations which did not affect binding profi-
ciency provided insights into the role of b strand 1 and
a helix 4 in facilitating the catalytic functions of the IS2
TPase (Table 2, rows 22 and 25). The 50% increase in
transposition frequency of the mutant with the A341T
mutation likely results from the substitution of a polar
residue at this conserved hydrophobic position in the
RISF, creating the potential for an additional specific or
stochastic contact with the terminus possessing the CA-
3’ dinucleotide. The W237R mutation, located three
residues from D240, a member of the catalytic triad,
replaced a highly conserved aromatic residue in the
RISF in b strand 1 with a basic amino acid and comple-
tely eliminated transposition without affecting the global
binding proficiency. This substitution replaced a residue
that is probably involved in positioning the DNA in the
catalytic pocket [82], a change that did not affect the
integrity of the b strand (see Discussion).
The middle interval
The V179L (GMF 101) substitution occurred in a helix
M5 (Figure 10a). This change disrupted binding (Figure
6f, lane 5) and completely eliminated transposition
(Table 2, row 26), a result which suggests that at least a
helices M4-M6 of the middle region of the protein,
which are aligned with the first three N-terminal helices
of the integrase protein (IN), contribute to the overall
structural and functional architecture needed to facili-
tate binding by the protein.
Discussion
Rationale for soluble expression of the GFP-tagged IS2
TPase
GFP has been used widely as a reporter or biological
marker [83], extensively in fusion constructs to deter-
mine the extent of solubility of target proteins, in pro-
tein folding assays and in directed evolution [44,84].
Although its use as an agent to facilitate the soluble
expression of proteins that misfold or aggregate when
overproduced in Escherichia coli has been approached
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actin [86]. We reasoned that, given its robust solubility,
it might be used to facilitate soluble expression of the
intractably insoluble IS2 TPase under native conditions.
The full length fusion protein achieves very efficient
binding to cognate DNA sequences
The inefficient binding to cognate DNA of full length
native or GFP-tagged IS2 TPase, purified to homogene-
ity, contrasts starkly with the extremely efficient binding
of the partially purified OrfAB-GFP utilizing residues at
both the N- and C-termini of the TPase. In addition,
footprinting studies reported elsewhere show that the
protein binds to both the protein binding and catalytic
domains of IRR, generating fully formed complexes
(Lewis et al, Protein-DNA interactions define the
mechanistic aspects of circle formation and insertion
reactions in IS2 transposition, submitted). In this study
we have not explored in detail the reasons for this dif-
ference but reports of inefficient binding of full length
TPases of insertion sequences are not uncommon. For
example, in IS911 [8,15] and in IS30 [28,29], both of
which transpose via the two-step circle-forming path-
way, successful footprinting studies have only been con-
ducted with truncated versions of the Tpase, which
retain the DNA binding domain and lack the C-termi-
nus. Inefficient binding was initially also reported for
IS50 [87,88] and in both IS50 [88] and IS911 [15] it has
been proposed that this is due to interference of binding
domain function by the C-terminus. Recently, a full
length calmodulin-binding peptide fusion derivative of
the IS256 TPase, which catalyzes circle formation in this
element [12], was shown to bind to the ends, but it did
so much less efficiently than N-terminal fragments con-
taining the DNA binding domain, lending additional
support to this hypothesis [89]. Other reports of ineffi-
cient binding by recombinant TPases in both prokaryo-
tic and eukaryotic transposons, such as IS903 [90], Tc1
[91] and TAG1 [92], has led to the speculation that
improper folding during the purification process may be
the cause of inefficient binding. Our results with the
partially purified IS2 TPase suggest that an unidentified
component or, speculatively, even the presence of
unspecific or IR DNA may be the agent which facilitates
and/or maintains proper folding in these TPases.
The DNA binding domain of IS2OrfAB consists of a three-
helix bundle with a defined HTH motif
The location of three a helices, which might comprise
the binding domain of the IS2 TPase at positions 13 to
26, 32 to 38 and 43 to 55, by the PHD secondary struc-
ture algorithm of PBIL [55] represents the best fit of
our data (compare Figures 9b and 11). The only discre-
pancy is our decision to include residues 56 to 58 in
helix 3 because substitutions S57G and L58I both nega-
tively impact binding and transposition. L58I substitutes
a residue whose most pronounced effect is its difficulty
in adapting to an a helix conformation because of its
branched b carbon for one which shows a distinct pre-
ference for being in a helices [93]. The absence of com-
plex formation (Figure 6c, lane 2) suggests that the
substitution destabilized the a helix and likely the entire
binding domain. We discuss the role that S57 plays in
the recognition helix of an HTH motif below. These
two substitutions suggest that residues 57 and 58 are
within helix 3 or, less likely (given the potential role of
S57 described below), are required for the stabilization
of the helix. The R13H substitution completely abol-
ished both binding and transposition (Figure 6a, lane 9)
by replacing a polar, hydrophilic, positively charged resi-
due that often has a structural role [94] with one which
is less likely to carry a charge, making it likely that helix
1 plays an important role in the structural architecture
responsible for binding the cognate DNA sequence in
IS2. These data suggest that the binding domain
includes all three helices and is comprised of residues
13 to 58 (Figure 11).
The HTH motif predicted by the HTH secondary
structure analysis protocol of PBIL [54] also represents
an excellent fit with our data. The motif includes resi-
dues M30 to K51 and is associated with helices 2 and 3
of the putative binding domain (compare Figures 9c and
11). The consensus sequence of Pabo and Sauer [95]
which generally characterizes the HTH motif in prokar-
yotes supports the claim that it resides in helices 2 and
3 (Figure 11). When this consensus sequence [ho-G/A-
(X)2]helix 1-[ho-G-ho-X]turn-[(X)3-I/L/V-...]helix2, is applied
to residues M30 to L58, (where ho is a hydrophobic resi-
due, and × is any residue) we see a very reasonable fit:
[V35-A36-R37-Q38]helix 1-[H39-G40-V41-A42]turn-
[A43-S44-Q45-L46....]helix2. The critical residues here (in
bold) are, (i) the optional hydrophobics (ho), V35 in
helix 1 and H39 and V41 in the turn (histidine has the
potential to be buried like a hydrophobic [93]) and (ii)
three conserved hydrophobics, A36 in helix 1, the invar-
iant glycine (G40) in the second position of the turn
(both weak hydrophobics) and L46 in helix 3 (Figure
11).
It is interesting that four of the nine randomly
induced substitutions in the binding domain affected
residues in this consensus sequence. A comparison of
the effects of the S44N substitution and of the R37Q/
S44N double replacement in helices 1 and 2 respectively
of the proposed HTH motif gives some additional
insight into the role of these two residues in the stabili-
zation of the HTH motif. Since the drastic effect of
S44N (no detectable binding and 80-85% reduction in
the transposition frequency, Figure 6a, lane 7) is
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reduction in binding and transposition frequency,
respectively, Figure 6b, lane 2), we make the following
assumptions: S44 and R37 are likely involved in interhe-
lix H-bonding and contribute to stabilizing the HTH. In
the S44N mutant derivative, arginine and asparagine are
apparently not as effective in H-bonding, resulting in a
destabilized motif. H-bonding by glutamine and aspara-
gine in the double mutant, however, appears to be par-
tially restored, most likely because of the increased
capacity of this pair of amino acids to form H-bonds
[94].
The fact that four of the seven mutations which dis-
rupted binding occurred in the second helix of this
HTH motif (Figure 11) supports the convention that it
is the recognition helix. Two of these substitutions,
R50H and S57G, help identify residues that are likely
involved in making specific DNA contacts. The R50H
substitution in the putative recognition helix produced a
protein derivative which generated the partially disso-
ciated complex in Figure 6a, lane 5 and completely
eliminated transposition. In this case the positively
charged arginine is replaced by an amino acid whose
flexibility in shedding its proton allows it to readily
assume a neutral state, making it less effective as a resi-
due involved in binding to DNA sequences [93] and
suggesting that R50 plays a pivotal role in recognizing
its cognate DNA sequence. Because the IS2 transposi-
tion pathway requires separate binding events for each
of the two steps, even a moderate reduction in binding
would probably have a drastic effect in reducing trans-
position frequency, as seen with R50H. S57G substitutes
a small residue without a side chain for a polar hydro-
philic residue with a fairly reactive OH group, which is
usually involved in forming hydrogen bonds. Since this
residue is located in the putative recognition helix, a
DNA-contact assignment to S57 could also explain the
effect of this substitution in generating the dissociated
complex in Figure 6c, lane 2.
Two substitutions, A42T and V35L, which produced
little or no change in the wild type phenotype, lend
additional support to our identification of the HTH
based on the Pabo and Sauer predictions. Replacement
of A42 in the four-residue turn with any small amino
acid would probably have little effect on protein func-
tion (A42T; Figure 6c, lane 3); in addition, the replace-
ment of the optional hydrophobic, V35, with leucine in
the first helix of the HTH would not be expected to
have a significantly negative effect (Figure 6b, lane 5) on
HTH function (see Figure 11). These results confirm
that in IS2, N-terminal helices 2 and 3 contain the HTH
motif with a four-residue turn between them. Thus the
IS2 binding domain consists of residues 13 to 26 which
f o r mh e l i x1 ,3 2t o3 8f o r mh e l i x2 ,( h e l i x1o ft h e
HTH; Figure 11), 39 to 42 form the turn, and 43 to 58
form helix 3 (helix 2 of the HTH; Figure 11). The A42T
mutation has an interesting phenotype in that it was
selected as a bright colony (see the legend to Table 3)
but is not toxic to the cell even though it is phenotypi-
cally a silent mutation. It is possible that its protein is
produced in lower amounts or that the mutation has
simply made the protein more soluble.
These results are in general accord with, and extend
the work of, Prere et al. [52], Hu et al. [5], Lei and Hu
[33] and Rousseau et al. [34] on IS3 family TPases. Hu
et al. predicted the existence of an HTH motif in the
IS2 TPase at residues 31 to 50 and Lei and Hu demon-
strated the loss of binding capability experimentally for
IS2 OrfA deletion derivatives lacking as few as the first
12 residues (likely destabilizing the formation of helix 1)
and as many as 57 residues from the N-terminus.
PSIPRED secondary structure analyses of the TPases of
all other prototypes of the principal subgroups of the
IS3 family show three helices whose positions are simi-
lar to those shown for IS2 (data not shown).
There is much evidence for multihelix binding
domains which include at least one HTH motif in
TPases. IS30, which transposes via a circle-forming
pathway, possesses an N-terminal binding domain with
two HTH motifs, one of which is a component of an H
+ HTH structure [28]. The MuA Ib and Ig DNA-bind-
ing subdomains which form bipartite binding structures
a r ec o m p o s e do ff i v ea n df o u ra helices, respectively,
each including an HTH motif [96,97]. In the case of the
Ib subdomain of MuA, all five helices are involved in
the interaction with the DNA. Similar results have been
reported for the TPases Tc3 [98] and the Tc1-like ele-
ment Sleeping Beauty [99] whose multihelix structures
with two HTH motifs are not dissimilar from those of
the homeodomain family of helix-turn-helix DNA-bind-
ing proteins [100] or the paired DNA binding domain
family [101].
The W49R substitution in the second and putative
recognition helix of the HTH generated a protein with
no negative effects on binding efficiency (Figure 6b, lane
3) but lacked any capacity for transposition (Table 2,
row 11). Resolution of this apparent contradiction has
led to the conclusion that W49 may not directly interact
with the protein binding domains of IRR and IRL. Fig-
ure 7 shows that few residues in the N-terminal helix 3
(B a-3) in IS2,a r ec o n s e r v e di nI S 3 family TPases. This
is expected for the recognition helices of these motifs
which have little identity in the sequences of their ends;
on the contrary, W49 in IS2 however, corresponds to
what has been described as one of the most highly con-
served of all residues in the TPases of the IS3 family
[34]. The ability of the W49R mutation to disrupt trans-
position but not binding in IS2, (even when a charged
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bic one) suggests that the function of W49 may extend
globally in the protein and is not confined to binding
functions of the HTH motif.
A similar but not identical inconsistency in the rela-
tionship between binding efficiency and transposition
was also observed with the equivalent W42 in IS911
[34]. There, the W42F mutant derivative which pro-
duced little to no binding efficiency with a truncated
OrfAB lacking the CAS, showed a strongly positive
result for in vivo transposition in the presence of the
CAS of the IS911 TPase. This suggested that the CAS
somehow had the ability to compensate for the defi-
ciency of the W42F substitution in facilitating binding.
Our results suggest that this conserved tryptophan in
IS3 family TPases may be involved in interacting with
the CAS of the protein, for example, by promoting the
folding which allows that motif to be correctly posi-
tioned in binding to the catalytic domain of IRR. W49R
may fail to communicate the level of accuracy in CAS
binding (for example, by permitting a minor misfolding)
that is needed to allow recombination, without affecting
regional DNA binding. Evidence for extensive binding of
the IS2 TPase to the catalytic domain of IRR (the donor
end in this insertion sequence) has been shown in con-
current footprinting studies described elsewhere (Lewis
et al, Protein-DNA interactions define the mechanistic
aspects of circle formation and insertion reactions in IS2
transposition, submitted) and the issue of the role of the
CAS in global binding of the protein is addressed in this
study in the discussion of CAS mutations which reduce
binding efficiency.
The IS2 TPase possesses a LZ-like oligomerization motif
at its N-terminus that facilitates binding to the ends of
the element
The sequence of the coiled coil motif of the IS2 OrfAB
TPase (residues 73-100; Figure 12a) differs in significant
ways from that of the canonical LZ. Indeed when this
sequence is tested on the 2-ZIP server (2zip.molgen.
mpg.de/cgi-bin/2zip.pl;[59]) a LZ is not predicted. In
this study, all five substitutions in the coiled coil domain
indicate that a LZ-like motif, whose function is required
for binding and transposition, exists within residues 73
to 100 in the IS2 TPase.
We have aligned the four OrfAB LZ-like heptads in
IS2 with corresponding sequences from prototype ele-
ments of the four other subgroups of the IS3 family
(Figure 12b). Haren et al. [30] have, however, created a
detailed alignment of putative LZ sequences from OrfA,
involving 15 members of the five subgroups (IS2,I S 3,
IS51,I S 150 and IS407)o ft h eI S 3 family and they have
specifically demonstrated the presence of a canonical LZ
motif with a four-heptad repeat in OrfAB of IS911
[30,31]. These alignments reveal, however, that the puta-
tive IS2 LZ-like motif is the only sequence in which only
two of the four d positions are occupied by leucine (L83
and L97) and that IS2 alone lacks the leucine residue at
the d position of the first heptad (for example, see A76-;
Figure 12b). However, three of the four hydrophobic
residues at the a positions (L73, I80 and L87) are occu-
pied by leucines or isoleucine. The fourth a position,
N94, in the fourth heptad is the buried polar asparagine,
which is essential for inter-subunit H-bonding in cano-
nical LZ structures [102]. Another significant difference
between this putative IS2 LZ-like motif and the canoni-
cal LZ is the restriction of ionic (g/e’ g’/e)s t a b i l i z i n g
salt bridges to the third and fourth heptads (Figure 12c).
It is possible, however, that weak non-ionic inter-subu-
nit stabilizing interactions between the first and second
heptads are brought about by the glutamine residues
(Q79 and Q84) in the g and e positions of these two
heptads. We propose, based on the analysis of all five
mutations, that stabilization of a potential LZ-like struc-
ture (Figure 12c) would be brought about as follows: the
N-terminal half of the structure would be relatively
weakly stabilized by the concerted action of the d-
located leucines at L83 in the second heptad, the a-
located hydrophobics L73 and I80 and by hydrogen
bonds at the g and e positions, Q79 and Q84, in the
first and second heptads respectively. The C-terminal
half of the motif, on the other hand would be more
strongly stabilized by the d-located leucines at L97, the
a-located asparagine (N94) whose buried hydrogen
bonds contribute significantly to stabilization of the zip-
per (both in the fourth heptad) and the canonical ionic
salt bridges generated by the g and e residues at E93
and K98 in the third and fourth heptads, respectively.
Thus, L83V and L97H affected the canonical d-located
leucines. The L83V substitution (Figure 6c, lane 5) com-
pletely abolished both binding and transposition, sug-
gesting that substitution of the C-b branched valine
residue destroyed the primary interaction for stabiliza-
tion at the N-terminus and consequently the entire LZ-
like motif. The phenotype of the Q79L substitution
appears to have affected the weak g/e’ g’/e inter-subunit
stabilizing reactions at the N-terminal end of the zipper-
like structure but, given that the primary stabilization
interaction is still present, it produced a less drastic phe-
notypic change insofar as binding efficiency is concerned
(Figure 6a, lane 4), compared to the replacement at
Leu
83 (L83V).
L97H, on the other hand, had a much less drastic
effect on binding (Figure 6a, lane 6), although transposi-
tion was all but abolished. The L97H substitution desta-
bilized the putative motif at its C-terminal end but the
two other strong stabilization interactions described
above appear to allow a level of oligomerization that
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Similarly, N94D altered the buried a-located asparagine
residue required for stabilization of the zipper but the
existence of the two remaining stabilization interactions
at the C-terminus appears to have influenced the pro-
duction of a phenotype similar to that of L97H (Figure
6c, lane 5).
The K89M substitution (Figure 12c) also abolished
transposition completely and provides further evidence
for a functional LZ-like motif. Its phenotype is consis-
tent with the location of K89 at a c-located position,
which is part of the solvent-exposed helical surface that
must be occupied by a hydrophilic residue. A hydropho-
bic residue would disrupt the formation of that surface
and subsequently abolish zipper function [103,104].
The CAS of the TPase of IS2 and other IS3 family
members share the functional properties of the three-
dimensional catalytic core of the TPase/RISF
The eight substitutions, W237R, L266P, H267D, R291H,
V301M, A341T, A341P and E391K (Table 2, rows 18-
25) fell into 3 a helices and 3 b strands of the putative
CAS (Figure 10b). Four of these (W237R, L266P,
H267D and V301M) impacted the putative b sheet of
the catalytic core and abolished transposition but only
W237R had no effect on binding (Figure 6f, lane 4), a
result that helps identify the function of W237 and of b
strand 1 in the CAS. Two of the remaining four muta-
tions, A341T and A341P, located adjacent to the third
member of the catalytic triad, E342, affected a highly
conserved hydrophobic residue in a helix 4 in the RISF,
that is, V151 in HIV-1 (Figure 10b; see also [105]).
A341T had no negative effect on binding efficiency (Fig-
ure 6b, lane 4) and enhanced the frequency of transposi-
tion by about 50% (Table 2, row 22), a result that also
sheds light on the function of a helix 4 in the IS2 CAS.
Substitutions were recovered in two other a helices,
E391K in a helix 6 and R291H in a helix 1. These and
H267D in b strand 3, which reduced but did not elimi-
nate binding, helped identify residues and elements
which likely function in binding the CAS to the catalytic
domain.
The W237R and A341T substitutions eliminated and
enhanced cleavage respectively, and provide strong evi-
dence, based on the deduced function of the two WT
residues, that the three-dimensional structure of the cat-
alytic core of the IS2 TPase functions similarly to that
in the RISF. W237R is highly conserved in b strand 1 of
the RISF and aligns with W61 in HIV-1 and RSV. The
location of this tryptophan, three residues from the first
of the catalytic aspartates (D240 in IS2 and D 64 in
HIV-1) on b strand 1, is consistent with its role, as
shown from crosslinking studies with W61 of HIV-1
[106], in interacting with the 3’ end of the DNA and
positioning it within the catalytic pocket. The ability of
W237R to eliminate transposition without affecting
binding could then be explained by a similar role for
W237.
The A341T substitution highlights the essential sup-
porting role of residues adjacent to E342 in a helix 4, in
the chemistry of cleavage and joining, and we draw this
conclusion from the extent of conservation in this a
helix in the RISF. For example, the co-crystal structure
of the Tn5 TPase has shown that Y319, R322, K330 and
K333, which flank E326 (the triad glutamic acid) in a
helix 4, are involved in making specific contacts with
the 3’ and 5’ ends (transferred and non-transferred
strands) of the catalytic domain of the DNA [67]. These
four residues are aligned directly, in a helix 4 of IS2,
with E336, N338, K346 and K349 (N338 and K349 are
highly conserved residues), which flank E342 [61] and
presumably have the same function as their equivalents
in Tn5. In addition, K346 and the conserved K349 in
IS2 are aligned with K156 and K159 in HIV-1 integrase
(Figure 10b). These two residues in IN have been shown
to contact the DNA, with K159 directly interacting with
the adenosine of the terminal CA-3’ dinucleotide, where
it is involved in orienting the DNA properly for cleavage
[83]. Earlier, van Gent et al. [107] had shown that a
K159V substitution in HIV-1 significantly slowed the
rate of integration without significantly reducing the
amount of integration in an overnight incubation. Their
implication was that this mutation reduced by one the
number of residues flanking E152 (the triad glutamic
acid) available for contact with the DNA and thus
reduced the efficiency of interaction between the protein
and the DNA. In addition, Calmels et al. [108] demon-
strated in HIV-1 that 75% of the random mutations
immediately flanking E152 th a tr e s u l t e di na ni n c r e a s e
in the amount of binding to a strand transfer substrate
included a V151T mutation, the homologue of A341T
in IS2. One can then account for the 50% increase in
transposition of A341T, by assuming that enhanced
interaction with the catalytic domain of IRR, due to an
additional specific or stochastic DNA contact by the
substituted threonine, produced the subsequent
enhancement. This is likely the case, given its proximity
to the four residues which putatively make contact with
the catalytic domain of the IS2 IRR and its location
adjacent to E342. These two results, with W237R and
A341T on b strand 1 and a helix 4 respectively, suggest
that the three-dimensional structures of these elements,
and subsequently that of the catalytic core, are function-
ally similar to those of the RISF.
We have been able to differentiate between substitu-
tions in the CAS which do not affect the binding effi-
ciency of the protein, W237R or A341T, those which
affected the structural integrity of the catalytic core and
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tion, A341P, L266P and V301M, (Figure 6e, lanes 2-4)
and those which reduce binding efficiency of the CAS to
the cognate DNA, such as H267D, R291H and E391K
(Figure 6a, lane 1 and 6d lanes 2-3); these last three pro-
duced partially dissociated complexes identifying resi-
dues that are likely important binding contacts between
the CAS and the catalytic domain. H267D replaced a
basic residue with a negatively charged one at a non-
conserved position on b strand 3. The enhanced level of
substrate dissociation is in accord with reduced contact
with the DNA. R291H substituted a weakly basic residue
at a position occupied by a conserved arginine in four of
t h ef i v es u b g r o u p si na helix 1 of the IS3 family. The
substitution reduced binding efficiency, likely compro-
mising the DNA anchoring function provided by Arg
291. E391K occurs in a helix 6, which is characterized
by two highly conserved residues, proline (P389 in IS2)
in RSV and the IS3 family and a glutamic acid or gluta-
mine in the RISF; E391K in IS2 altered the latter and
the replacement of the acidic residue with the basic
lysine reduced the overall binding affinity to the DNA
in the catalytic domain, without completely eliminating
it. The phenotypes of these mutations (H267D, R291H
and E391K) suggest that their wild type residues are cri-
tical contacts which facilitate the binding of the CAS to
the catalytic domain of IRR.
On the other hand, A341P, the helix-breaking proline
substitution in a helix 4, altered a conserved hydropho-
bic residue in the RISF, significantly reducing complex
formation. L266P altered a conserved hydrophobic resi-
due in b strand 3 of the RISF and V301M altered a very
hydrophobic, conserved residue in the IS3 family in b
strand 4, associated with the second aspartate of the cat-
alytic triad (D306); both of these completely eliminated
complex formation. The fact that all three of these sub-
stitutions replaced very hydrophobic residues and elimi-
nated binding suggests that their principal effect was to
disrupt the a helix or b strand, or the putative b sheet
and thus the catalytic core, the integrity of which is
clearly essential for proper folding of the full length pro-
tein and thus global binding.
These results underscore the importance that binding
of the catalytic core to the CD plays in regional and glo-
bal binding of the full length protein. On one level the
W49R substitution in the recognition helix of the HTH
apparently failed to coordinate the necessary level of
accuracy of binding of the catalytic core to the DNA of
the catalytic domain (most likely due to a minor folding
impairment), eliminating transposition but nevertheless
permitting global binding. However, a full length protein
with a mutation of a single anchoring residue in its cata-
lytic core, which may not alter the structural integrity of
the protein, significantly impacts global binding,
manifested by partial dissociation of the complex. From
this we conclude that the binding reactions with wild
type proteins shown in Figures 2 and 6, in which all of
the DNA is driven into the complex, result from fully
formed complexes in which both the DNA binding
domain and the CAS of the protein are fully complexed
to the ends. This conclusion is supported by data show-
ing extensive protection of the protein binding and cata-
lytic domains of IRR or of the abutted ends of the
minicircle junction (Lewis et al, Protein-DNA interac-
tions define the mechanistic aspects of circle formation
and insertion reactions in IS2 transposition, submitted).
Impaired binding by either domain of the protein thus
produces dissociation of the complex.
The integrity of a middle interval contributes to the
binding capability of the IS2 TPase
The V179L substitution affects a hydrophobic residue
that is functionally conserved in a helix M5 in the RISF
(Figure 10a). Two of the three residues conserved in the
IS3 family are also conserved in the RISF and V179L
affected one of them. The disruption of binding and
abolition of transposition in IS2 likely resulted from the
replacement of the C-b branched valine, which affected
the backbone of the a helix, distorting or disrupting it
[93]. The result suggests that at least a helices M4 to
M6 of the middle interval of the protein, which align
with good conservation with the first three a helices of
IN, are critical to the functional architecture of the pro-
tein that relates to global binding to the cognate IS2
DNA.
Conclusions
These results validate the strategy of the GFP-tagged
approach to obtaining, under native conditions, prepara-
tions of a full length, soluble, active protein like the IS2
TPase that is usually insoluble when prepared under
native conditions and refractory to whole protein struc-
ture-function or biophysical studies when solubilized.
This strategy has resulted, for the first time (among cir-
cle forming insertion sequences with a two-step trans-
position pathway), in the recovery of a full length
protein which is capable of very efficient binding in
vitro to cognate DNA and the formation of fully formed
complexes (Lewis et al, Protein-DNA interactions define
the mechanistic aspects of circle formation and insertion
reactions in IS2 transposition, submitted) involving resi-
dues at both the N- and C-termini of TPase. In addition
the fluorescence-based random mutagenesis approach to
exploring structure-function relationships has helped
refine our understanding of those relationships in IS2
and the IS3 family TPases by teasing out residues that
facilitate binding, oligomerization and (as they relate to
the integrases) catalysis, as well as those that define
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Methods
Bacterial strains and media
E. coli strain JM105 (New England Biolabs) was used for
most procedures involving plasmid DNA preparation,
cloning and the lacZ papillation assay. DNA transforma-
tion was carried out into supercompetent XL1 Blue cells
(Stratagene Inc, Santa Clara, CA, USA) for reactions
requiring cloning and overexpression of the fused orfAB
and GFPuv genes in pLL2522. BL21(DE3)pLysS cells
(Novagen-EMD4Biosciences, La Jolla, CA, USA) were
used for over expression of the OrfAB-GFP fusion product
cloned into the pTWIN2 vector (New England Biolabs).
Cultures were routinely grown in lysogeny broth (LB)
media at 37°C, supplemented where necessary with car-
benicillin (Cb, 50 μg/mL), kanamycin (Km, 40 μg/mL)
or chloramphenicol (Cm, 20 μg/mL). For the overex-
pression of pGLO, pLL2522 and pLL2524-XXX (plas-
mids with the GMF mutations), cultures were grown at
28°C in 2x YT media supplemented with Cb and arabi-
nose (6 mg/mL).
DNA procedures
Plasmid DNA preparation was carried out using the
standard alkaline lysis procedure of the Wizard DNA
Purification System (Promega Corp., Madison, WI,
USA) for in-labarotory protocols. The Pure Link HQ
Miniplasmid Purification Kit (Invitrogen Corp., Carls-
bad, CA, USA) was used in the preparation of DNA
samples for outsourced sequencing reactions (see
below).
Restriction endonuclease digestion was carried out
with enzymes and buffers from New England Biolabs.
Diagnostic gels were made with 0.8% Seakem agarose
and preparative gels were made with 0.6% Seaplaque
Low Melting Temperature agarose (Cambrex Corp., East
Rutherford, NJ, USA). DNA was purified from prepara-
tive gels with Gelase (Epicentre Biotechnologies, Madi-
son, WI, USA) following the manufacturer’s instructions
and concentrated in a Microcon-100 Filter Device
(Millipore, Billerica, MA, USA) to a 50 μLv o l u m e .T h e
solution was dried down to a pellet in a Savant Speed-
Vac DNA concentrator, resuspended in 12 μLu l t r a p u r e
H2O and frozen at -20°C until use. Standard cloning
procedures were as previously described [7].
Standard PCR and PCR-mediated in vitro site-directed
mutagenesis were carried out with the Vent DNA poly-
merase (New England Biolabs) used in accordance with
the manufacturer’s instructions. The reaction protocols
were as described earlier [6]. PCR products were cleaned
up with the Direct PCR Purification Buffer and the
Wizard PCR Preps Resin (Promega Corp.).
Plasmid constructs and mutagenizing oligonucleotides
pLL2522 which contained the fused orfAB and GFPuv
genes (Figure 2e) was prepared following the procedure
illustrated in Figure 2.
pGLO-ATG2 containing 3’-located EcoRI-NheIc l o n -
ing sites (Figure 2a) was created by removing an EcoRI
site located adjacent to the two stop codons (bold upper
c a s e )a tt h e3 ’ end of GFPuv with the oligonucleotide
(all mutagenizing sites in this section are in bold lower
case) 5’GGATCATCAGGTACCGAGCgCGtATTCAT-
TATTTGTAGAGCTCATCCATGCC3’ and creating a
new cassetting EcoR1 site upstream of the existing NheI
site (in upper case, containing the first two codons of
GFP) and destroying the ATG start codon at the 5’ end
of the gene, with the oligonucleotide 5’TCCCCT
TCCCCGCTATGgATCAGCTGAgaattcTT
CTCCTTCTTAAAGTTAAA3’.
pLL2521HK (Figure 2d) containing an EcoRI-NheI cas-
setted orfAB gene was created in successive steps by
removing the upstream EcoRI site in pLL18 (Figure 2b)
with the oligonucleotide 5’AGACTATCACTTATCC
GCGGAACAGTCTAGAGCTCcccctcACTGGCCGTC3’,
placing EcoRI adjacent to the IS2 start codon
(pLL2509A; Figure 2c) with the oligonuclotide
5’ACTAGTTTTTAGACCGTCATTGGAgaattcAT-
GATTGATGTGTTAGGGCC3’, adding an NheI site and
altering the adjacent stop codon at the 3’ end of IS2
orfAB to create pLL2520 with the oligonucleotide
5’GGGCCCgcgctagcACCGGTTATTTCCAGACATC
TGTTATCACTTAACC3’ and adding a 6X HIS tag
downstream of the IS2o r f A Bstart codon (Figure 2d)
with oligonucleotide 5’GTATGcatcatcatcatcatcatagca-
gatatctggtattgagtataagcATTGATGTCTAAGGGCCG-
GAG3’Finally, in order to fuse the EcoRI - KpnI cassetted
orfAB-GFPuv fusion sequence (Figure 2e) to the Km
r
reporter gene, a procedure needed for the creation of
lacZ papillation assay constructs, a KpnI site was added
adjacent to and downstream of the NheIs i t e( u p p e r
case lettering) in the sequence that connects orfAB to
the Km
r gene. For this we used the primer 5’AACT-
GATCCAGGGCCCGggtaccAGCTAGCACCAGTTA
TTTC3’.
pLL2522 was produced by cloning the cassetted
EcoR1-NheI orfAB gene into pGLO-ATG2 (Figure 2e).
pUH2509, a construct used for lacZ papillation assays,
containing IS2 with the frame fused orfAB gene from
pLL18 (Figure 2b) was created as follows. IRL in pLL18
was deleted and the weak indigenous E-10 promoter
(upper case lettering) conserved while adding a SacII
site to form pLL2509A (Figure 2c), into which the XbaI-
SacII cassetted lacZ gene could be cloned. We used the
oligonucleotide 5’CCAGTGGAATTCGAGCTCTA-
GACTGTTccgcggATAAGTGATAGTCTTAATAT-
TAGTTTTTTAGACTAGTCATTGG3’. lacZ was
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modified to add the necessary SacII site, generating
pLL135II using 5’GGTACCGGGGATCCgccgAGACAT-
GATAAGATACATTGATGAGTTTGG3’. The 5’ end of
lacZ was modified to remove the lacUV5 promoter, to
add an XbaIs i t ea sw e l la st h eI S 2 IRL (upper case let-
tering) generating LL135IRLLZ. All three reading frames
reading into the IRL sequence lacked stop codons. We
used the oligonucleotide 5’ATGTTCTTTCCTCGAGtc-
tagaTAGACTGGCCCCCTGAATCTCCAGACAAC-
CAATATCACTTAATTATTGCCG-
TAAGCCGTGGCCG3’.T h eXbaI-SacII fragment from
pLL135IRLLZ was cloned into pLL2509A to produce
plasmid pUH2509, which contained a 6.4 kb version of
IS2 consisting of (from 5’ to 3’): IRL, the promoterless
lacZ gene sequence, the orfAB sequence without func-
tional left or right ends, the Km
r gene and IRR.
pUH2523, the construct containing the fused orfAB::
GFPuv genes, used for lacZ papillation assays, was cre-
ated as follows. (i) orfAB linked to the Km
r gene in
pLL2521HK is cassetted within EcoRI and KpnIr e s t r i c -
tions sites (Figure 2d), so in order to add the Km
r repor-
ter gene to the fused orfAB::GFP genes we replaced
orfAB in pLL2521HK (Figure 2d) with the EcoRI-KpnI
cassetted orfAB::GFP sequence shown in Figure 2e, to
create pLL2523. (ii) The lacZ papillation assay plasmid
pUH2509 possesses an SpeI site downstream of the E-10
promoter of IS2orfAB and an NruI site within the Km
r
reporter gene, as do all constructs in which Km
r is pre-
sent as a reporter gene (see, for example pLL2521HK in
Figure 2d). The SpeI-NruI fragment from pUH2509 was
replaced by the corresponding fragment from pLL2523
to create pUH2523. Similarly, SpeI-NruI fragments from
pLL2524-XXX, plasmids containing mutated orfAB
genes (see below), were used to create lacZ papillation
plasmids pUH2524-XXX.
pUH2523ΔorfAB, the null mutation used as a control
in lacZ papillation assays (Table 2, row 1), was created
by deleting a 1743 bp fragment between two MfeI
restriction sites, 103 bp from the start of the IS2orfAB
sequence and 156 bp from the end of the GFPuv
sequence in pUH2523, followed by blunt ligation of the
sites.
pTW2orfAB::GFP was created by cloning the fused
orfAB::GFP genes into the pTWIN2 vector of the
IMPACT system (Intein Mediated Purification with an
Affinity Chitin-binding Tag; New England Biolabs) for
the purposes of improving the purification of the fusion
protein. The construct was cloned into the N-terminal
multiple cloning site of the vector by first creating a
SbfIs i t ec l o s et ot h ee x i s t i n gEcoRI site with 5’GGCA-
TACATGAATTCCTCGAGGcctgcaggCTGCG-
TATCCGGTGACACC3’ to accommodate the EcoRI/
SbfI cassetted orfAB::GFP sequence.
Creation and cloning of mutations in IS2 orfAB from a
PCR-based random mutagenesis protocol
The GeneMorph II Random Mutagenesis Kit (Strata-
gene) was used to create mutations within orfAB in
pLL2521HK (Figure 2d) using a 30-cycle PCR-based
protocol. Primers were M13F (forward) and KmR1
(reverse; [6]). Mutations were generated at very low, low
and medium rates (900 ng of target DNA within 3.6 μg
of plasmid DNA; 500 ng of target within 2.0 μgo fp l a s -
mid DNA; and 250 ng of target within 1.0 μg of plasmid
DNA respectively). PCR products were cloned into the
EcoRI-NheI sites of pGLO-ATG2, transformed into
XL1-Blue Supercompetent cells and plated onto LB plus
Cb plus arabinose agar. After 72 hours at 37°C, plates
were examined for brightly fluorescing colonies among a
background of less brightly fluorescing colonies. Plas-
mids from the brighter fluorescing clones carrying
mutations in the orfAB sequence were identified as
pLL2524-XXX where XXX stands for 001-110.
LacZ papillation assays
Papillation was best observed when pUH2509, pUH2523
or pUH2524-XXX plasmid DNA was transformed into
JM105 cells. The DNA concentration was titrated to
produce about 50 to 60 transformants per plating on to
LB plus Km plus Cb plus arabinose agar. Plates were
incubated in airtight bags to minimize drying. The num-
bers of papillae plateaued after 20 to 25 days at 37°C.
Preparation of the wild type and mutant OrfAB-GFP
fusion proteins under native conditions
pLL2522 and other mutant plasmid DNA were trans-
formed into XLI-Blue cells (Stratagene), plated on to LB
plus Cb plus arabinose agar and incubated for 48 hours
at 37°C. A single fluorescing colony was inoculated into
10.0 mL of similarly supplemented 2x YT broth and
incubated overnight at 28°C. After centrifugation, the
pellet was checked for fluorescence, washed in 3.0 mL
Native Wash Buffer pH 8.0 (50 mM sodium phosphate
monobasic monohydrate, 300 mM NaCl), resuspended
in 3.0 mL Bug Buster Protein Extraction Reagent (Nova-
gen-EMD4Biosciences) supplemented with 1.0 uL of
Benzonase (Novagen-EMD4Biosciences) per 10.0 mL
overnight (o/n) culture and 3.0 uL of Protease Arrest
(Calbiochem-EMD4Biosciences La Jolla, CA, USA) per
mL of lysate and nutated at 4°C for 30 minutes. If
necessary, the suspension was subjected to a single
round of freezing and thawing to complete lysis. The
lysate was checked for bright fluorescence before and
after centrifugation at 16,000 × g for 1 hour at 4°C.
6xHis-tag purification of the protein was achieved by
gravity flow affinity chromatography using Ni-NTA
agarose (Qiagen Valencia, CA, USA) under native condi-
tions essentially following the manufacturer’s
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bed of the nickel-charged resin in a 5.0 mL column and
chromatographic separation followed with UV light. The
protein bound as a tight brightly fluorescing band at the
top of the column and remained bound through wash-
ings with 10 to 60 mM Imidazole when a slight dissocia-
tion of the band was observed. To circumvent continued
dissociation, the band was eluted with 250 mM Imida-
zole and its progress through the column followed. Peak
fractions (fluorometrically determined) were subjected
to diagnostic 12% PAGE using Ac:Bis (30%:8%) polya-
crylamide gels (Figure 4a). Fractions showing both the
74 kDa OrfAB-GFP and the 17 kDa OrfA proteins were
pooled (approximately 700 uL), concentrated to about
75 uL in a YM-10 Microcon Centrifugal Filter Device
(Millipore), dialyzed overnight in 300 mM NaCl, 50 mM
tris(hydroxymethyl)amino methane (Tris-Cl), pH 8.0
and 1.5 mM dithiothreitol using Slide-A-Lyzer cassettes
(Pierce/Thermo Scientific Rockford, IL, USA) and stored
in 50% glycerol at -20°C. Concentrations of GFP in the
sample shown in Figure 4a were measured with spectro-
photometry at 280 nm and 397 nm while those of the
wild type and mutant versions of the fused OrfAB-GFP
proteins were measured at 397 nm. Comparative levels
of fluorescence of GFP and the fusion proteins were
measured fluorometrically and used to confirm the con-
centration data.
For the overexpression of the OrfAB-GFP fusion pro-
tein in the pTWIN2 derivative (IMPACT, New England
Biolabs), plasmid pTWorfAB::GFP was transformed into
BL21(DE3)pLysS cells. Single colonies were inoculated
into 10 mL 2xYT plus Cb plus Cm and grown overnight
at 37°C. Two milliliters of this starter culture was inocu-
lated into 120 mL of the same medium (to establish an
optical density (OD) of 0.2) and grown at 37°C to an
OD of 0.8 when it was induced with 1.0 mM isopropyl
b-D-1-thiogalactopyranoside and allowed to grow over-
night at 16°C. The culture was lysed as described above
and the cleared lysate loaded onto the chitin column.
The protein was purified per the manufacturer’s instruc-
tions with binding and elution monitored by UV light-
induced fluorescence. Peak fractions were collected
pooled and analyzed as described above, purified on ion
exchange Q-sepharose columns (HiTrap Q XL, GE
Healthcare) following the manufacturer’s instructions,
and concentrated, dialyzed and stored as described
above.
Electrophoretic mobility shift assays
Oligonucleotides used
Annealed 50-mer oligonucleotides containing the 41 bp
I R Rs e q u e n c ew e r eu s e di na l lb u to n eo ft h eE M S A
experiments (Figure 6a-e). The upper strand was labeled
at the 5’ end with g
32P-ATP. Primer A - upper strand
(the IRR sequence is within the square brackets):
5’GGATCC[TTAAGTGATAACAGATGTCTGGAAA-
TATAGGGGCAAATCCA]GCG3’.P r i m e rB-l o w e r
strand: 5’CGC[TGGATTTGCCCCTATATTTCCAGA-
CATCTGTTATCACTTAA]GGATCC3’.
Reactions shown in Figure 6f utilized annealed 87-mer
oligonucleotides containing the IRR sequence. The top
strand (primer A) was labeled at its 5’ end with g
32P-
ATP. Primer A - 5’GCTGACTTGACGGGACGGG-
GATCC[TTAAGTGATAACAGATGTCTGGAAATA-
TAGGGGCAAATCCA]ATCGACCTGCAGGCATA-
TAAGC3’.P r i m e rB-5 ’GCTTATATGCCTGCAGG
TCGAT[TGGATTTGCCCCTATATTTCCAGACAT
CTGTTATCACTTAA]GGATCCCCGTCCCGTCAAGT
CAGC3’.
5’-end labeling and annealing of the primers
A2 0μL labeling reaction contained 40 units of T4 poly-
nucleotide kinase in 1X T4 polynucleotide kinase reac-
tion buffer (New England Biolabs), 20 μM of the primer
(upper strand) and 50 μCi of g
32P-ATP. The reaction
was incubated at 37°C for 30 minutes and heat-killed at
90°C for 5 minutes. A 100-μL annealing reaction con-
tained 10 rmol and 13 rmol of the labeled and unla-
beled strands respectively, 20 mM Tris-Cl pH 8.0 and
100 mM NaCl. The reaction was placed in a boiling
water bath, cooled to 65°C, held there for 15 minutes
and allowed to cool to room temperature.
EMSA
Binding of the TPase to its cognate DNA was carried
out for 30 minutes at room temperature (20°C) in a 15-
uL reaction mixture of 20 mM Tris-Cl pH 8.0, 1 mM
ethylenediaminetetraacetic acid, 5.0 μg/mL calf thymus
DNA, 10 nM of the radioactively labeled annealed pri-
mers and 0.13 μM of the partially purified preparation
of the OrfAB-GFP fusion protein. Reactions were sepa-
rated on 5% native polyacrylamide gels at 4°C for an
average of 450 volt hours (Vhrs) (see Figure 6).
Secondary structure algorithms and protein alignment
tools
The ExPASy SWISS PROT translation toolkit [49] of the
Swiss Institute of Bioinformatics was used to translate
DNA sequences from the prototypes of the principal
subgroups of the IS3 family, that is, IS2,I S 3,I S 51,a n d
IS407 plus IS911 of the IS3 subgroup and IS861 of the
IS150 subgroup, into protein sequences. Similar transla-
tions were done for sequences of the HIV-1 and RSV
integrases. The ClustalW2 multiple alignment tool [50]
was used for the alignment of protein sequences in Fig-
ure 7. Structure-based alignments in Figure 10 were
determined from the sequences shown in Figure 7, from
published RSV and HIV-1 sequences [73,109,110] from
the alignments of Fayet et al. [60] and Rezsohazy et al.
[61] and from the PSIPRED secondary structure
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groups and the two integrases. In these aligned
sequences, functionally conserved non-polar hydropho-
bic residues were identified as h1 when all sequences
possessed only very hydrophobic residues (L, I, V, C, M,
F or W) and h2 when less hydrophobic residues are pre-
sent or the conserved residues are only found in fewer
than 80% of the sequences. Three different algorithms
were used for secondary structure predictions: the
PSIPRED server[51], the PROF Secondary Structure Pre-
diction Protocol [53] using the Bioinformatics Informa-
tion toolkit of the Max Planck Institute for
Developmental Biology and the PHD Secondary Struc-
ture Analysis Algorithm [55] from the secondary analy-
sis prediction protocol of PBIL (pbil.univ-lyon.fr; [54]).
A PCOILS algorithm for coiled coils from the Bioinfor-
matics Information toolkit of the Max Planck Institute
for Developmental Biology [57,58] was used to predict
the presence of a coiled coil motif and the 2ZIP server
[59] from the same institution was used to predict the
presence of a LZ within the coiled coil motif.
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